D. Rognan et al., RATIONAL DESIGN OF NONNATURAL PEPTIDES AS HIGH-AFFINITY LIGANDS FOR THE HLA-B-ASTERISK-2705 HUMAN-LEUKOCYTE ANTIGEN, Proceedings of the National Academy of Sciences of the United Statesof America, 92(3), 1995, pp. 753-757
From the three-dimensional structure of the class I major histocompati
bility complex (MHC) HLA-B82705 protein, several nonnatural peptides w
ere designed either to optimize the interactions of one peptide amino
acid (position 3) with its HLA binding pocket (pocket D) or to simplif
y the T-cell receptor-binding part by substitution with organic spacer
s. The stability of each MHC-ligand complex was simulated by 150-ps mo
lecular dynamics in a water environment and compared with that of the
natural complexes. All peptides were synthesized and tested for bindin
g to the class I MHC protein in an in vitro assembly assay. As predict
ed from the computed atomic fluctuations and buried surface areas of M
HC-bound ligands, bulky hydrophobic side chains at position 3 enhance
the binding of a nonameric peptide to the KLA-B27 protein. Furthermore
, it was possible to simplify half of the peptide sequence (residues 4
-8) by replacement with organic fragments without altering the affinit
y of the designed ligands for the class I MHC protein. This study cons
titutes an initial step toward the rational design of nonpeptide class
I MHC ligands for use in the selective immunotherapy of autoimmune di
seases associated with particular HLA alleles.